{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:24:01Z","timestamp":1757615041356,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijrobp.2025.05.010","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:13:17Z","timestamp":1756969997000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hodgkin's Disease\u2014How We Got Here!"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-0194","authenticated-orcid":false,"given":"Richard T.","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.05.010_bib0001","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-53-5-877","article-title":"Lymphosarcoma: The effects of therapy and survival in 1,269 patients in a review of 30 years\u2019 experience","volume":"53","author":"Rosenberg","year":"1960","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0002","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/78.4.553","article-title":"The radical radiotherapy of regionally localized Hodgkin\u2019s disease","volume":"78","author":"Kaplan","year":"1962","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0003","first-page":"1268","article-title":"Extended-field radical radiotherapy in advanced Hodgkin\u2019s disease: Short-term results of 2 randomized clinical trials","volume":"26","author":"Kaplan","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0360-3016(85)90357-8","article-title":"The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984","volume":"11","author":"Rosenberg","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0005","series-title":"Radium Therapeutics","first-page":"84","author":"Finzi","year":"1913"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1148\/1.3.161","article-title":"The radiation treatment of Hodgkin\u2019s disease with particular reference to mediastinal involvement","volume":"1","author":"Desjardins","year":"1923","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0007","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/00016923109138214","article-title":"Notre m\u00e9thode de roentgenth\u00e9rapie de la lymphogranulomatose (Hodgkin): R\u00e9sultats \u00e9loign\u00e9s","volume":"12","author":"Gilbert","year":"1931","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0008","first-page":"299","article-title":"A study of survival in Hodgkin\u2019s disease treated radiologically","volume":"63","author":"Peters","year":"1950","journal-title":"Am J Roentgenol Radium Ther"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0009","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/97.2.425","article-title":"Surgical staging of abdominal involvement in unselected patients with Hodgkin\u2019s disease","volume":"97","author":"Glatstein","year":"1970","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-73-6-881","article-title":"Combination chemotherapy in the treatment of advanced Hodgkin\u2019s disease","volume":"73","author":"Jr","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0011","first-page":"183","article-title":"Hodgkin\u2019s disease: A revised clinical classification and an approach to the treatment of its localized form","volume":"15","author":"Brown","year":"1957","journal-title":"Stanford Med Bull"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0012","first-page":"1225","article-title":"Evidence for an orderly progression in the spread of Hodgkin\u2019s disease","volume":"26","author":"Rosenberg","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0013","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7","article-title":"Combination chemotherapy of Hodgkin\u2019s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP","volume":"36","author":"Bonadonna","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0014","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD, or MOPP alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0015","first-page":"733","article-title":"Leukaemias, non-Hodgkin\u2019s lymphomas and solid tumors in patients treated for Hodgkin\u2019s disease","volume":"1","author":"Coleman","year":"1982","journal-title":"Cancer Surv"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0016","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin's disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0017","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2005.09.085","article-title":"Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin\u2019s lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group","volume":"23","author":"Meyer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0018","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the international lymphoma radiation oncology group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/annonc\/7.suppl_4.S99","article-title":"Hodgkin\u2019s disease\u2013the role of radiation therapy in advanced disease","volume":"7","author":"Hoppe","year":"1967","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0020","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.1995.13.5.1080","article-title":"Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin\u2019s disease: A preliminary report","volume":"13","author":"Bartlett","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0021","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","article-title":"Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: An Intergroup Study coordinated by the Eastern Cooperative Oncology Group (E2496)","volume":"31","author":"Gordon","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0022","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1200\/JCO.2011.38.0410","article-title":"Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin\u2019s lymphoma","volume":"30","author":"Younes","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0023","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.05.010_bib0024","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2016.67.3467","article-title":"Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure","volume":"34","author":"Armand","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625004742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625004742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:19:50Z","timestamp":1757071190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625004742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0360301625004742"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hodgkin's Disease\u2014How We Got Here!","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}